$78.9B
$198 Million
0.0% of portfolio
1,945
Q2 2025
Added 55.72%
$265M
$2.16 Million
0.0% of portfolio
450
Q3 2024
Reduced 30.77%
$0
$1.79 Million
0.0% of portfolio
82
Q1 2023
Reduced 90.08%
Gorilla Technology Group Inc
-
$348 Million
0.0% of portfolio
-
Q1 2025
New
$162M
$34.8 Million
0.0% of portfolio
5,359
Q2 2025
Added 3.32%
$110M
$2.09 Million
0.0% of portfolio
4,857
Q2 2025
Added 34.51%
$376M
$1.04 Million
0.0% of portfolio
598
Q2 2025
New
$2.64B
$2.94 Million
0.0% of portfolio
120
Q3 2024
New
-
$29,000
0.0% of portfolio
-
Q2 2025
New
$6.18B
$3.47 Million
0.0% of portfolio
71
Q2 2025
Reduced 47.79%
$0
$23.6 Million
0.0% of portfolio
629
Q2 2025
Reduced 8.31%
$0
$1.08 Million
0.0% of portfolio
54
Q1 2025
Reduced 30.77%
-
$12.3 Million
0.0% of portfolio
-
Q2 2025
New
$733M
$17.6 Million
0.0% of portfolio
1,250
Q1 2024
New
$0
$79.2 Million
0.0% of portfolio
1,416
Q2 2025
New
$421M
$16.5 Million
0.0% of portfolio
1,400
Q4 2024
Added 40.0%
$81.6M
$8.76 Million
0.0% of portfolio
6,000
Q4 2021
New
$7.56B
$653,000
0.0% of portfolio
15
Q4 2024
Reduced 6.25%
Kiniksa Pharmaceuticals Intl
-
$3.14 Million
0.0% of portfolio
-
Q2 2025
Added 15.0%
$4.58B
$13.1 Million
0.0% of portfolio
1,035
Q2 2025
Added 3.5%
$6.53B
$18.6 Million
0.0% of portfolio
3,122
Q2 2025
Added 0.29%
$9.28B
$21 Million
0.0% of portfolio
1,000
Q1 2025
Reduced 14.53%
$37.2B
$20.8 Million
0.0% of portfolio
242
Q1 2025
Added 163.04%
$29.8B
$486 Million
0.0% of portfolio
43,295
Q2 2025
Added 0.68%
$20.7B
$13.5 Million
0.0% of portfolio
76
Q2 2024
New
$2.2B
$59.6 Million
0.0% of portfolio
1,670
Q2 2025
Added 6.37%
$3.61B
$10,000
0.0% of portfolio
1
Q4 2024
Reduced 97.37%
$80.6M
$58,000
0.0% of portfolio
150
Q1 2025
Reduced 40.0%
$0
$25.1 Million
0.0% of portfolio
225
Q1 2025
Reduced 17.28%
$9.58B
$198 Million
0.0% of portfolio
21,204
Q2 2025
Added 1,661.13%
$1.54B
$3.5 Million
0.0% of portfolio
50
Q2 2025
New
$4.09B
$1.45 Million
0.0% of portfolio
26
Q1 2025
Added 100.0%
$11B
$69.9 Million
0.0% of portfolio
1,660
Q2 2025
Added 6.62%
$1.17B
$333 Million
0.0% of portfolio
50,437
Q2 2025
Added 4,085.64%
$52.7B
$420 Million
0.0% of portfolio
1,667
Q2 2025
Added 27.45%
$8.16B
$3.74 Million
0.0% of portfolio
100
Q1 2022
New
$35.1B
$736,000
0.0% of portfolio
9
Q1 2025
New
$35.6B
$215 Million
0.0% of portfolio
89,250
Q1 2025
Reduced 40.0%
$34.3B
$68.7 Million
0.0% of portfolio
701
Q2 2025
Added 11.98%
$0
$47.5 Million
0.0% of portfolio
2,450
Q4 2021
New
$10.9B
$29 Million
0.0% of portfolio
153
Q2 2025
Reduced 70.52%
Karyopharm Therapeutics Inc
-
$14 Million
0.0% of portfolio
-
Q1 2025
New
$25.2B
$686 Million
0.0% of portfolio
4,813
Q2 2025
Added 2.21%
$32.8B
$544 Million
0.0% of portfolio
3,129
Q2 2025
Added 4.06%
-
$686,000
0.0% of portfolio
-
Q2 2025
New
$24.9B
$21.9 Million
0.0% of portfolio
326
Q2 2025
Added 2,228.57%
$2.33B
$91.1 Million
0.0% of portfolio
8,693
Q2 2025
Reduced 0.46%
$49.3B
$107 Million
0.0% of portfolio
789
Q2 2025
Reduced 24.43%
$1.44B
$4.17 Million
0.0% of portfolio
411
Q2 2025
Reduced 41.29%
$12.6B
$18.6 Million
0.0% of portfolio
61
Q2 2025
Added 15.09%